Squamocolumnar junction visibility, age, and implications for cervical cancer screening programs.

导出 OA

翻译打印收藏纠错

作者： Kanan T,Desai ^[1] ; Natasha,Hansen ^[2] ; Ana-Cecilia,Rodriguez ^[2] ; Brian,Befano ^[3] ; Didem,Egemen ^[2] ; Julia C,Gage ^[2] ; Nicolas,Wentzensen ^[2] ; Catya,Lopez ^[4] ; Jose,Jeronimo ^[2] ; Silvia,de Sanjose ^[5] ; Mark,Schiffman ^[2]

作者单位： Clinical Epidemiology Unit, Clinical Genetic Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States; Internal Medicine Residency, Icahn School of Medicine at Mount Sinai, Elmhurst Hospital Center, New York, United States. Electronic address: kanan.desai@nih.gov. ^[1] Clinical Epidemiology Unit, Clinical Genetic Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States. ^[2] University of Washington, Seattle, United States; Information Management Services, MD, United States. ^[3] League Against Cancer, Peru, Lima, Peru. ^[4] Clinical Epidemiology Unit, Clinical Genetic Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States; ISGlobal Barcelona, Spain. ^[5]

关键词 Age Cervical cancer screening Squamocolumnar junction Transformation zone Visibility

主题词女(雌)性(Female);人类(Humans);老年人(Aged);宫颈肿瘤(Uterine Cervical Neoplasms);癌症早期检测(Early Detection of Cancer);宫颈非典型增生(Uterine Cervical Dysplasia);活组织检查(Biopsy)

DOI 10.1016/j.ypmed.2024.107881

PMID 38286273

发布时间 2024-03-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交